These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effect of etoposide for urogenital tumors].
    Author: Kinjo T, Murase T, Aota Y, Shimoji T, Mitsuya H.
    Journal: Gan To Kagaku Ryoho; 1985 Jun; 12(6):1267-71. PubMed ID: 4004290.
    Abstract:
    Ten patients with urogenital tumors were treated with Etoposide. The dose schedule was 100 mg i.v. daily for 5 days and was repeated after 4-5 weeks. One patient with ureteral tumor experienced partial remission for 60 days and minor regression was achieved in 3 patients. The major side effects were leukopenia (60%) and thrombocytopenia (40%). Mean WBC nadir of 1050/mm3 occurred at 13.5 days and recovered quickly after a further 7.5 days.
    [Abstract] [Full Text] [Related] [New Search]